Clinuvel Pharmaceuticals Limited

CUVL·NasdaqGS
Compare
5.58+0.02 (+0.43%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.56
Open5.70
Day range5.585.80
52-week range5.538.92
Off day high−3.75%
Off 52-week high−37.40%
Volume10.53K
Avg. volume (3M)13.02K
Market cap281.92M
EPS (TTM)0.4500
Forward P/E—
P/E ratio (TTM)12.41
Dividend yield0.64% (0.0400)
Beta (5Y)—
Shares outstanding50.49M
Short interest—
Earnings date—
Analyst target—
Profit margin—

Against its peers

Compare in full ›
CUVL YDES EYPT FBIO ENTA SLGL
Market cap 281.92M 448.36M 278.35M 70.37M 358.24M 237.04M
P/E (TTM) 12.4 — — 0.8 — —
Forward P/E — — -1.2 -1.2 -5.2 -8.7
Price/book 1.5 1.4 1.7 0.4 3.5 4.9
Dividend yield 0.64% — — — — —
1-year change −31.07% −63.54% −74.51% −23.57% +8.79% +79.65%
Today +0.43% −5.94% −2.35% −1.17% −1.60% +0.88%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CUVL news ›
@kalkineau·Positive

Is Clinuvel Pharmaceuticals Setting Up For Its AGM (ASX:CUV)?

Are London Plans Next for Ionic Rare Earths (ASX:IXR)? The headline item is a short notice of the annual general meeting, pointing owners of the stock to the full meeting documents and proxy form. A section cleansing statement and an…

@StockTitan_net·

[6-K] Clinuvel Pharmaceuticals Ltd Current Report (Foreign Issuer)

Shell third quarter 2026 update note REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2026 Level 22, 535 Bourke Street (Address of principal executive…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.